HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

48,XXYY, 48,XXXY and 49,XXXXY syndromes: not just variants of Klinefelter syndrome.

AbstractUNLABELLED:
Sex chromosome tetrasomy and pentasomy conditions occur in 1:18,000-1:100,000 male births. While often compared with 47,XXY/Klinefelter syndrome because of shared features including tall stature and hypergonadotropic hypogonadism, 48,XXYY, 48,XXXY and 49,XXXXY syndromes are associated with additional physical findings, congenital malformations, medical problems and psychological features. While the spectrum of cognitive abilities extends much higher than originally described, developmental delays, cognitive impairments and behavioural disorders are common and require strong treatment plans. Future research should focus on genotype-phenotype relationships and the development of evidence-based treatments.
CONCLUSION:
The more complex physical, medical and psychological phenotypes of 48,XXYY, 48,XXXY and 49,XXXXY syndromes make distinction from 47,XXY important; however, all of these conditions share features of hypergonadotropic hypogonadism and the need for increased awareness, biomedical research and the development of evidence-based treatments.
AuthorsNicole Tartaglia, Natalie Ayari, Susan Howell, Cheryl D'Epagnier, Philip Zeitler
JournalActa paediatrica (Oslo, Norway : 1992) (Acta Paediatr) Vol. 100 Issue 6 Pg. 851-60 (Jun 2011) ISSN: 1651-2227 [Electronic] Norway
PMID21342258 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Review)
Copyright© 2011 The Author(s)/Acta Paediatrica © 2011 Foundation Acta Paediatrica.
Topics
  • Humans
  • Hypogonadism (genetics)
  • Klinefelter Syndrome (diagnosis, genetics, psychology)
  • Male
  • Phenotype
  • Sex Chromosome Disorders (diagnosis, genetics, psychology)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: